Treatment of wet age-related macular degeneration by ranibizumab in "real life" in France: treatment behaviours and associated visual outcome

被引：3
|
作者：
Souied, Eric H. [1 ]
Cohen, Salomon-Yves [2 ]
de Pouvourville, Gerard [3 ]
Dupeyron, Gerard [4 ]
Latour, Elisabeth [5 ]
Ponthieux, Anne [5 ]
Weber, Michel [6 ]
机构：
[1] UPEC, Creteil Univ Eye Clin, Interc Hosp Creteil, Creteil, France
[2] Ophthalm Ctr Laser & Med Imagery, Paris, France
[3] ESSEC, Cergy Pontoise, France
[4] Univ Nimes Hosp, Dept Ophthalmol, F-30006 Nimes, France
[5] Novartis Pharma SAS, Rueil Malmaison, France
[6] Hotel Dieu Univ Hosp, Dept Ophthalmol, Nantes, France
来源：
ACTA OPHTHALMOLOGICA | 2015年 / 93卷 / 02期
关键词：
DISEASE;
D O I：
10.1111/aos.12517
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E179 / E180
页数：2
相关论文
共 50 条
  • [21] Ranibizumab according to need: A treatment for age-related macular degeneration
    Spaide, Richard
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 143 (04) : 679 - 680
  • [22] Pegaptanib in the treatment of wet, age-related macular degeneration
    Vinores, Stanley A.
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2006, 1 (03): : 263 - 268
  • [23] Bevasiranib for the Treatment of Wet, Age-Related Macular Degeneration
    Garba, Adinoyi O.
    Mousa, Shaker A.
    OPHTHALMOLOGY AND EYE DISEASES, 2010, 2 : 75 - 83
  • [24] Controversies in the treatment of wet age-related macular degeneration
    Moreno, Sandra Flores
    Paloma, Javier Bautista
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 145 (05) : 937 - 937
  • [25] Objective Visual Assessment of Antiangiogenic Treatment for Wet Age-Related Macular Degeneration
    Baseler, Heidi A.
    Gouws, Andre
    Crossland, Michael D.
    Leung, Carmen
    Tufail, Adnan
    Rubin, Gary S.
    Morland, Antony B.
    OPTOMETRY AND VISION SCIENCE, 2011, 88 (10) : 1255 - 1261
  • [26] PROGNOSTIC FACTORS AND OUTCOME OF INTRAVITREAL RANIBIZUMAB TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Narayan, Daniel
    Meucke, James
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 40 : 113 - 113
  • [27] Cost Comparison of Intravitreal Aflibercept With Bevacizumab and Ranibizumab for the Treatment of Wet Age-Related Macular Degeneration
    Shaikh, Adeel H.
    Toussaint, Brian W.
    Miller, Daniel M.
    Petersen, Michael R.
    Foster, Robert E.
    Riemann, Christopher D.
    Hutchins, Robert K.
    Sisk, Robert A.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2015, 46 (01): : 62 - 66
  • [28] FREQUENCY OF RANIBIZUMAB INJECTIONS FOR THE TREATMENT OF WET AGE-RELATED MACULAR DEGENERATION: CANADIAN REAL-WORLD UTILIZATION DATA
    Davies, B.
    Gonder, J.
    Blouin, J.
    Zaour, N.
    VALUE IN HEALTH, 2012, 15 (07) : A575 - A575
  • [29] Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
    Garcia-Layana, Alfredo
    Figueroa, Marta S.
    Arias, Luis
    Araiz, Javier
    Maria Ruiz-Moreno, Jose
    Garcia-Arumi, Jose
    Gomez-Ulla, Francisco
    Isabel Lopez-Galvez, Mara
    Cabrera-Lopez, Francisco
    Manuel Garcia-Campos, Jose
    Mones, Jordi
    Cervera, Enrique
    Armada, Felix
    Gallego-Pinazo, Roberto
    JOURNAL OF OPHTHALMOLOGY, 2015, 2015
  • [30] Occurrence of macular hematoma after ranibizumab treatment for age-related macular degeneration
    Azar, Georges
    Mauget-Faysse, Martine
    Nyouma, Jasmine
    Cohen, Salomon Yves
    Coscas, Florence
    Francais-Maury, Catherine
    Souied, Eric
    Soubrane, Gisele
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2015, 25 (02) : 163 - 167
12345